Join to View Full Profile
1760 W Montecito WaySan Diego, CA 92103
Phone+1 858-534-5858
Fax+1 858-534-8180
Dr. Rosenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1970 - 1971- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1967 - 1968
University of Rochester School of Medicine and DentistryClass of 1958
Certifications & Licensure
CA State Medical License 1972 - 2025
MD State Medical License 1969 - 1981
Publications & Presentations
PubMed
- An eRNA transcription checkpoint for diverse signal-dependent enhancer activation programs.Lishuan Wang, Wei Yuan, Amir Gamliel, Wubin Ma, Seowon Lee
Nature Genetics. 2025-04-01 - 7 citationsEnhancer-promoter specificity in gene transcription: molecular mechanisms and disease associations.Meyer J Friedman, Tobias Wagner, Haram Lee, Michael G Rosenfeld, Soohwan Oh
Experimental & Molecular Medicine. 2024-04-01 - 9 citationsSignal-induced enhancer activation requires Ku70 to read topoisomerase1-DNA covalent complexes.Yuliang Tan, Lu Yao, Amir Gamliel, Sreejith J Nair, Havilah Taylor
Nature Structural & Molecular Biology. 2023-02-01
Grant Support
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D RiskCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Multiplexed Single Nucleus RNA and ATAC-seq Sequencing and Cortical Organoids: Transformative Insights into Down SyndromeUNIVERSITY OF CALIFORNIA, SAN DIEGO2020–2025
- Regulatory Landscape of the Aging Human OvaryCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Enhancer Connectomes in Regulation of Gene ExpressionUNIVERSITY OF CALIFORNIA, SAN DIEGO1998–2025
- Enhancer Connectomes in Regulation of Gene ExpressionUNIVERSITY OF CALIFORNIA, SAN DIEGO1998–2025
- Phase Separation: A New Phase in Decoding Enhancer-dependent Critical Transcriptional Programs by Nuclear ReceptorsUNIVERSITY OF CALIFORNIA, SAN DIEGO1982–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
